| Rank | Bedrijf | |
|---|---|---|
| 1 | MSD | |
| 2 | Bayer | |
| 3 | BASF | |
| 4 | IMCD | |
| 5 | AkzoNobel | |
| 6 | Abbott | |
| 7 | SABIC | |
| 8 | Johnson & Johnson Innovative Medicine | |
| 9 | GlaxoSmithKline (GSK) | |
| 10 | Dow Benelux | |
| Runners-up | ||
| 1 | Novartis | |
| Strategie | Score | |
| 1 | MSD | |
| 2 | AkzoNobel | |
| 3 | BASF | |
| 4 | Abbott | |
| 5 | Bayer | |
| 6 | Johnson & Johnson Innovative Medicine | |
| 7 | IMCD | |
| 8 | SABIC | |
| 9 | Dow Benelux | |
| 10 | GlaxoSmithKline (GSK) | |
| 11 | Novartis | |
| Klant | Score | |
| 1 | IMCD | |
| 2 | Bayer | |
| 3 | BASF | |
| 4 | AkzoNobel | |
| 5 | Abbott | |
| 6 | MSD | |
| 7 | SABIC | |
| 8 | Novartis | |
| 9 | Johnson & Johnson Innovative Medicine | |
| 10 | Dow Benelux | |
| 11 | GlaxoSmithKline (GSK) | |
| Technologie | Score | |
| 1 | MSD | |
| 2 | Abbott | |
| 3 | Bayer | |
| 4 | BASF | |
| 5 | SABIC | |
| 6 | IMCD | |
| 7 | AkzoNobel | |
| 8 | GlaxoSmithKline (GSK) | |
| 9 | Johnson & Johnson Innovative Medicine | |
| 10 | Novartis | |
| 11 | Dow Benelux | |
| Organisatie | Score | |
| 1 | IMCD | |
| 2 | Bayer | |
| 3 | AkzoNobel | |
| 4 | BASF | |
| 5 | SABIC | |
| 6 | Abbott | |
| 7 | Johnson & Johnson Innovative Medicine | |
| 8 | MSD | |
| 9 | Novartis | |
| 10 | GlaxoSmithKline (GSK) | |
| 11 | Dow Benelux | |